Masimo Corporation (NASDAQ:MASI) EVP Yongsam Lee sold 5,000 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $89.89, for a total value of $449,450.00. Following the completion of the sale, the executive vice president now directly owns 74,000 shares in the company, valued at approximately $6,651,860. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Masimo Corporation (MASI) traded down $1.93 on Friday, reaching $86.00. The company’s stock had a trading volume of 261,418 shares, compared to its average volume of 384,306. The stock has a market cap of $4.37 billion, a P/E ratio of 32.37 and a beta of 0.75.

Masimo Corporation (NASDAQ:MASI) last issued its quarterly earnings data on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.53 by $0.17. The firm had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The business’s revenue for the quarter was up 15.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.52 EPS. analysts expect that Masimo Corporation will post 2.96 earnings per share for the current year.

WARNING: “Masimo Corporation (MASI) EVP Sells $449,450.00 in Stock” was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece on another domain, it was stolen and reposted in violation of US and international trademark and copyright laws. The original version of this piece can be read at https://www.americanbankingnews.com/2017/11/03/masimo-corporation-masi-evp-sells-449450-00-in-stock.html.

Several brokerages recently commented on MASI. Zacks Investment Research raised Masimo Corporation from a “hold” rating to a “buy” rating and set a $98.00 price target on the stock in a research note on Thursday. BTIG Research upgraded Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research report on Monday, August 14th. BidaskClub downgraded Masimo Corporation from a “hold” rating to a “sell” rating in a research report on Wednesday, August 9th. Stifel Nicolaus reiterated a “buy” rating and issued a $108.00 price objective (up previously from $105.00) on shares of Masimo Corporation in a research report on Thursday, August 3rd. Finally, Roth Capital lifted their price objective on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research report on Wednesday, July 19th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and five have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $97.17.

Hedge funds have recently added to or reduced their stakes in the company. Prudential Financial Inc. raised its position in shares of Masimo Corporation by 14.4% during the second quarter. Prudential Financial Inc. now owns 553,215 shares of the medical equipment provider’s stock worth $50,442,000 after acquiring an additional 69,810 shares during the last quarter. American Century Companies Inc. raised its position in shares of Masimo Corporation by 98.0% during the second quarter. American Century Companies Inc. now owns 209,474 shares of the medical equipment provider’s stock worth $19,100,000 after acquiring an additional 103,656 shares during the last quarter. D L Carlson Investment Group Inc. raised its position in shares of Masimo Corporation by 32.4% during the second quarter. D L Carlson Investment Group Inc. now owns 46,240 shares of the medical equipment provider’s stock worth $4,216,000 after acquiring an additional 11,315 shares during the last quarter. State Street Corp raised its position in shares of Masimo Corporation by 10.4% during the second quarter. State Street Corp now owns 1,547,728 shares of the medical equipment provider’s stock worth $141,121,000 after acquiring an additional 146,212 shares during the last quarter. Finally, Robeco Institutional Asset Management B.V. raised its position in shares of Masimo Corporation by 27.1% during the second quarter. Robeco Institutional Asset Management B.V. now owns 1,095,353 shares of the medical equipment provider’s stock worth $99,872,000 after acquiring an additional 233,412 shares during the last quarter. Institutional investors own 82.96% of the company’s stock.

Masimo Corporation Company Profile

Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.

Insider Buying and Selling by Quarter for Masimo Corporation (NASDAQ:MASI)

Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with MarketBeat.com's FREE daily email newsletter.